decisionhealth Newsletters, Coder Pink Sheets - 2005 Issue 5 (May)
Drugs: Some of your most expensive drugs are most often denied by Medicare
Subscribe or sign in to view the full article.
Article Overview
This article examines Medicare utilization and denial patterns for commonly billed drugs and supplies in pain clinics, using data from anesthesiology, pain medicine, and interventional pain management office or clinic claims. It is aimed at coders, billers, and practice managers who want to understand why certain drug claims are denied, how payment variability affects revenue, and what general documentation and coverage areas deserve review. The discussion includes broad guidance on local coverage determination review, diagnosis payability checks, advance beneficiary notices, dosage-to-unit alignment, and distinctions among billed drug and fluid items.
Why This Topic Matters
The topic matters because expensive drug denials can create substantial unreimbursed costs in pain practices, and mismatches between charges, documentation, and payer expectations can affect both compliance and revenue. The article helps readers identify categories of claims that may warrant closer internal review and carrier policy comparison.
Article Sections
-
Overview of Medicare denial patterns for pain-clinic drugs
Introduces the article’s Medicare claims analysis and the general issue of denials affecting high-cost drugs used in pain management settings.
-
How to review denials and coverage issues
Discusses broad areas practitioners may compare against carrier policy, including coverage determinations, diagnosis payability, and documentation practices.
-
Drug unit, dosage, and fee alignment
Covers general billing concerns related to matching billed units to the reported amount and aligning charges with the unit value of the drug.
-
Injectable anesthetics and denial trends
Summarizes the article’s discussion of denial patterns for injectable anesthetics used in pain procedures and the broader reimbursement context.
-
Other billing patterns noted in the data
Reviews additional drug and fluid billing patterns identified in the analysis, including items discussed in relation to pump refills, sedation, and infusion fluids.
What You Will Learn
- How Medicare denial patterns can affect drug reimbursement in pain management practices
- What broad claim-review areas are emphasized when drug denials occur
- How drug unit reporting and fee alignment are discussed in relation to billing accuracy
- Which general categories of drugs and supplies are highlighted as recurrent billing issues
- Why certain billed items are discussed as part of pain-clinic reimbursement trends
Who Should Read This
- Medical coders
- Billing staff
- Practice managers
- Pain management administrators
- Revenue cycle professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com